Dr. Jonathan Trent, GIST Specialist at Sylvester Cancer Center and Dr. Andrew Rosenberg, also a GIST Specialist at Sylvester, have co-authored a book dedicated to sarcoma diagnosis and management with other sarcoma experts (Dr. Raphael Pollock and Dr. Thomas F. DeLaney) specifically for the purpose of giving oncologists a credible authority to ‘go-to’ for sarcoma knowledge. Dr. Trent is a member of our Pediatric & SDH-Deficient GIST Consortium. Both Trent and Rosenberg have presented multiple times  Life Fest, GDOLs, and LRG Webcasts, speaking on GIST and sarcoma.

The American Cancer Society’s estimates for soft tissue sarcomas in the United States for 2020 are: About 13,130 new soft tissue sarcomas will be diagnosed, the most common types being malignant fibrous histiocytoma, liposarcoma, and leiomyosarcoma, compared to breast cancer estimates which estimate that 276,480 new cases of invasive breast cancer will be diagnosed in women.

This textbook is available from Springer Publishing. The description from their site reads:

Trent/Rosenberg sarcoma bookSarcomas: Evidence-Based Diagnosis and Management is the most comprehensive clinical reference on sarcomas available to oncologists and trainees. Presenting a compilation of the current knowledge of specific soft tissue and bone sarcomas, this accessible resource on diagnosis and management is the most practical in the market. Led by the world’s foremost sarcomas experts in medical oncology, surgical oncology, radiation oncology, gynecologic oncology, orthopedic surgery, radiology, and pathology, the book addresses the general principles of each major medical discipline, provides details on each major sarcoma subtype, and presents the evidence for standard frontline, adjuvant, and novel treatment approaches such as immunotherapy, cellular therapies, and more.

The book begins with general principles of diagnosis and management for each discipline in the field, covering specialties from medical oncology to radiology. Following the chapters on general principles, are chapters characterizing the most prevalent subtypes of sarcoma including their estimated incidence, common presenting symptoms, diagnostic approach, radiographic features and essential imaging, key diagnostic features, molecular characteristics, approaches to treatment, recommended follow up, the metastatic potential as well as evidence-based therapeutic approaches. Each chapter ends with a summary of caveats, clinical pearls, pitfalls, and solutions as well as a case study from the clinician’s point of view. The book ends with chapters focusing on new approaches to treatment and the development of therapeutics to combat sarcoma using immunotherapy, cellular therapy, and interventional radiology. Numerous tables and disease-based images support the text and provide key information for quick reference. Presenting detailed evidence and authoritative clinical guidance throughout, Sarcomas is a “one-stop” guide for any clinician diagnosing, treating, or managing patients suffering from these heterogenous diseases.

Key Features:
Provides the standards of care and evidence base for treatment of each major sarcoma subtype
Covers all new treatment paradigms and FDA approvals
Includes numerous quick reference tables and high-quality color images
Presents over 20 practical case studies from leading clinicians in the field
Purchase includes access to the ebook for use on most mobile devices or computers

“Sarcomas: Evidence-based Diagnosis and Management” is a comprehensive compendium of information about sarcoma provided by THE experts on each topic. Each type of sarcoma is discussed in tremendous detail with a challenging case at the end of each chapter to integrate knowledge with real world experience. Importantly, “Sarcomas” is available in a user-friendly electronic format for the busy clinician to use on the run in clinic on a computer, tablet or smartphone. This resource is one of the important tools for physicians, nurses, PAs, pharmacists, fellows, residents and medical students in any sarcoma clinic.

– Dr. Jonathan Trent, Leader, Sarcoma Disease Group, Associate Director, Clinical Research,
University of Miami, Sylvester Comprehensive Cancer Center